Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Neurochem
2016 Aug 01;1383:384-96. doi: 10.1111/jnc.13675.
Show Gene links
Show Anatomy links
Reconstitution of synaptic Ion channels from rodent and human brain in Xenopus oocytes: a biochemical and electrophysiological characterization.
Mazzo F
,
Zwart R
,
Serratto GM
,
Gardinier KM
,
Porter W
,
Reel J
,
Maraula G
,
Sher E
.
???displayArticle.abstract???
Disruption in the expression and function of synaptic proteins, and ion channels in particular, is critical in the pathophysiology of human neuropsychiatric and neurodegenerative diseases. However, very little is known regarding the functional and pharmacological properties of native synaptic human ion channels, and their potential changes in pathological conditions. Recently, an electrophysiological technique has been enabled for studying the functional and pharmacological properties of ion channels present in crude membrane preparation obtained from post-mortem frozen brains. We here extend these studies by showing that human synaptic ion channels also can be studied in this way. Synaptosomes purified from different regions of rodent and human brain (control and Alzheimer's) were characterized biochemically for enrichment of synaptic proteins, and expression of ion channel subunits. The same synaptosomes were also reconstituted in Xenopus oocytes, in which the functional and pharmacological properties of the native synaptic ion channels were characterized using the voltage clamp technique. We show that we can detect GABA, (RS)-α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, and NMDA receptors, and modulate them pharmacologically with selective agonists, antagonists, and allosteric modulators. Furthermore, changes in ion channel expression and function were detected in synaptic membranes from Alzheimer's brains. Our present results demonstrate the possibility to investigate synaptic ion channels from healthy and pathological brains. This method of synaptosomes preparation and injection into oocytes is a significant improvement over the earlier method. It opens the way to directly testing, on native ion channels, the effects of novel drugs aimed at modulating important classes of synaptic targets. Disruption in the expression and function of synaptic ion channels is critical in the pathophysiology of human neurodegenerative diseases. We here show that synaptosomes purified from rodent and human frozen brain (control and Alzheimer disease) can be studied both biochemically and functionally. This method opens the way to directly testing the effects of novel drugs on native ion channels.
Arbilla,
Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats.
1985, Pubmed
Arbilla,
Pharmacological profile of the imidazopyridine zolpidem at benzodiazepine receptors and electrocorticogram in rats.
1985,
Pubmed
Bagal,
Ion channels as therapeutic targets: a drug discovery perspective.
2013,
Pubmed
Bayés,
Human post-mortem synapse proteome integrity screening for proteomic studies of postsynaptic complexes.
2014,
Pubmed
Bernareggi,
Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes.
2007,
Pubmed
Bertolino,
Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus.
1993,
Pubmed
Broad,
Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
2006,
Pubmed
,
Xenbase
Carbone,
Ca currents in human neuroblastoma IMR32 cells: kinetics, permeability and pharmacology.
1990,
Pubmed
Carlin,
Isolation and characterization of postsynaptic densities from various brain regions: enrichment of different types of postsynaptic densities.
1980,
Pubmed
Chatzidaki,
Pharmacological Characterisation of Nicotinic Acetylcholine Receptors Expressed in Human iPSC-Derived Neurons.
2015,
Pubmed
Chini,
Neuronal-type alpha-bungarotoxin receptors and the alpha 5-nicotinic receptor subunit gene are expressed in neuronal and nonneuronal human cell lines.
1992,
Pubmed
Dage,
Pharmacological characterisation of ligand- and voltage-gated ion channels expressed in human iPSC-derived forebrain neurons.
2014,
Pubmed
Day,
Distribution of AMPA-selective glutamate receptor subunits in the human hippocampus and cerebellum.
1995,
Pubmed
Dunkley,
A rapid Percoll gradient procedure for preparation of synaptosomes.
2008,
Pubmed
Eusebi,
Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: a potent tool for expanding functional information.
2009,
Pubmed
,
Xenbase
Gardinier,
Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8.
2016,
Pubmed
Grant,
Synaptopathies: diseases of the synaptome.
2012,
Pubmed
GRAY,
The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.
1962,
Pubmed
Huettner,
Block of N-methyl-D-aspartate-activated current by the anticonvulsant MK-801: selective binding to open channels.
1988,
Pubmed
Limon,
Loss of functional GABA(A) receptors in the Alzheimer diseased brain.
2012,
Pubmed
,
Xenbase
Maher,
Discovery and Characterization of AMPA Receptor Modulators Selective for TARP-γ8.
2016,
Pubmed
Malayev,
Inhibition of the NMDA response by pregnenolone sulphate reveals subtype selective modulation of NMDA receptors by sulphated steroids.
2002,
Pubmed
,
Xenbase
Miledi,
Microtransplantation of neurotransmitter receptors from cells to Xenopus oocyte membranes: new procedure for ion channel studies.
2006,
Pubmed
,
Xenbase
Miledi,
Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes.
2004,
Pubmed
,
Xenbase
Mitew,
Altered synapses and gliotransmission in Alzheimer's disease and AD model mice.
2013,
Pubmed
Palma,
Expression of human epileptic temporal lobe neurotransmitter receptors in Xenopus oocytes: An innovative approach to study epilepsy.
2002,
Pubmed
,
Xenbase
Pirker,
GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.
2000,
Pubmed
Sanna,
Expression of native GABAA receptors in Xenopus oocytes injected with rat brain synaptosomes.
1996,
Pubmed
,
Xenbase
Selkoe,
Alzheimer's disease is a synaptic failure.
2002,
Pubmed
Straughan,
Evaluation of bicuculline as a GABA antagonist.
1971,
Pubmed
Tovar,
The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro.
1999,
Pubmed
Traynelis,
Glutamate receptor ion channels: structure, regulation, and function.
2010,
Pubmed
van Spronsen,
Synapse pathology in psychiatric and neurologic disease.
2010,
Pubmed
Voglis,
The role of synaptic ion channels in synaptic plasticity.
2006,
Pubmed
Wenzel,
Distribution of NMDA receptor subunit proteins NR2A, 2B, 2C and 2D in rat brain.
1995,
Pubmed
Williams,
Ifenprodil discriminates subtypes of the N-methyl-D-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors.
1993,
Pubmed
,
Xenbase
Young,
Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
2008,
Pubmed
,
Xenbase
Zwart,
Perampanel, an antagonist of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, for the treatment of epilepsy: studies in human epileptic brain and nonepileptic brain and in rodent models.
2014,
Pubmed
,
Xenbase
Zwart,
Unique pharmacology of heteromeric α7β2 nicotinic acetylcholine receptors expressed in Xenopus laevis oocytes.
2014,
Pubmed
,
Xenbase
Zwart,
Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors.
2008,
Pubmed
,
Xenbase